‘What aren’t we facing?’: Immunization leader lays bare challenges to the monkeypox response

In the United States, the circumstances around monkeypox vaccine are a good news, bad news kind of story.
The good news is that there is a licensed vaccine. At the start of many outbreaks of new or rare diseases, there are no vaccines. But the bad news quickly overtakes the good. Demand outstrips supply, both domestically and internationally. In the U.S., the federal government has decided to use fractional doses — one-fifth of a normal dose, per person — to try to stretch supplies. Read the rest…